Share
Journal Information
Most often read
2725
SEA 2022 standards for the comprehensive control of cardiovascular riskJ.M. Mostaza, X. Pintó, P. Armario, L. Masana, J.T. Real, P. Valdivielso, T. Arrobas-Velilla, R. Baeza-Trinidad, ... L. Vila
Clin Investig Arterioscler. 2022;34:130-79
2725
Open access
Open Article
1994
Inflammation and atherogenic markers in patients with type 2 diabetes mellitusMaría Aurora Maravilla Domínguez, María de Lourdes Zermeño González, Elias Roberto Zavaleta Muñiz, Verónica Adriana Montes Varela, Cesar Antonio Irecta Nájera, Nicté Selene Fajardo Robledo, Soraya Amalí Zavaleta Muñiz
Clin Investig Arterioscler. 2022;34:105-12
1994
Open Article
1678
Diabetes mellitus and cardiovascular risk: an update of the recommendations of the Diabetes and Cardiovascular Disease Working Group of the Spanish Society of Diabetes (SED, 2021)Francisco Arrieta, Juan Pedro-Botet, Pedro Iglesias, Juan Carlos Obaya, Laura Montanez, Gonzalo Fernando Maldonado, Antonio Becerra, Jorge Navarro, ... Manuel Aguilar
Clin Investig Arterioscler. 2022;34:36-55
1678
Open Article
1534
Adherence to non-pharmacological treatment is associated with the goals of cardiovascular control and better eating habits in Mexican patients with type 2 diabetes mellitusLubia Velázquez-López, Paulina Segura Cid del Prado, Eloísa Colín-Ramírez, Abril Violeta Muñoz-Torres, Jorge Escobedo-de la Peña
Clin Investig Arterioscler. 2022;34:88-96
1534
Open Article
1414
HDL-cholesterol concentration and risk of SARS-CoV-2 infection in people over 75 years of age: A cohort with half a million participants from the Community of MadridCarlos Lahoz, Miguel A. Salinero-Fort, Juan Cárdenas, Fernando Rodríguez-Artalejo, Mariana Díaz-Almiron, Pilar Vich-Pérez, F. Javier San Andrés-Rebollo, Ignacio Vicente, José M. Mostaza
Clin Investig Arterioscler. 2022;34:113-9
1414
Open Article
1120
Situation in 2020 of the requirements for the use of PCSK9 inhibitors in Spain: Results of a national surveyCarlos Guijarro, Fernando Civeira, José López-Miranda, Luis Masana, Juan Pedro-Botet, Xavier Pintó, Pedro Valdivielso, José María Mostaza
Clin Investig Arterioscler. 2022;34:10-8
1120
Open access
Open Article
1047
Challenges and perspectives of the double burden of malnutrition in Latin AmericaÁngela Hernández-Ruiz, Casandra Madrigal, María José Soto-Méndez, Ángel Gil
Clin Investig Arterioscler. 2022;34 Supl 1:3-16
1047
Open Article
1046
Application of the individualized objectives defined by the European 2019 lipid guidelines in patients with type 2 diabetesDavid Martín Enguix, Abraham Hidalgo Rodríguez, María Sánchez Cambronero, Juan Carlos Aguirre Rodríguez
Clin Investig Arterioscler. 2022;34:19-26
1046
Open Article
965
Bempedoic acid as a PPARα activator: New perspectives for hepatic steatosis treatment in a female rat experimental modelRoger Bentanachs, Ana Magdalena Velázquez, Rosa María Sánchez, Marta Alegret, Juan Carlos Laguna, Núria Roglans
Clin Investig Arterioscler. 2022;34:57-67
965
Open Article
834
LDL as a therapeutic targetÁngel Díaz Rodríguez, Teresa Mantilla Morató
Clin Investig Arterioscler. 2022;34:271-84
834
Open Article
788
Familial chylomicronemia syndrome: The first case reported in EcuadorKarla Johana Garay García, Ricardo Javier Chong Menendez, Juan Patricio Nogueira, Jefferson Santiago Piedra Andrade
Clin Investig Arterioscler. 2022;34:326-9
788
Open Article
767
Update on new forms of tobacco useJorge Francisco Gómez Cerezo, José Enrique López Paz, Jacinto Fernández Pardo
Clin Investig Arterioscler. 2022;34:330-8
767
Open access
Open Article
743
Dietary patterns in non-alcoholic fatty liver disease (NAFLD): Stay on the straight and narrow path!Niki Katsiki, Anca Pantea Stoian, Manfredi Rizzo
Clin Investig Arterioscler. 2022;34 Supl 1:23-30
743
Open Article
728
Dyslipidemia observatory: Treatment of hypercholesterolemia in Spain, context and levers for improvement in clinical practiceJuan Cosín-Sales, Raquel Campuzano Ruiz, José Luis Díaz Díaz, Carlos Escobar Cervantes, María Rosa Fernández Olmo, Juan José Gómez-Doblas, José María Mostaza, Juan Pedro-Botet, ... Pedro Valdivielso
Clin Investig Arterioscler. 2022;34:253-60
728
Open Article
621
Relationship between the coronary artery calcium quantification and gut microbiota composition in subjects without previous cardiovascular disease: A pilot studyIsabel Ortega-Madueño, Javier Modrego, Rubén Gómez-Gordo, Adriana Ortega-Hernández, Leopoldo Pérez de Isla, Juan Carlos Muñoz, M. Luisa Nieto, Dulcenombre Gómez-Garre
Clin Investig Arterioscler. 2022;34:205-15
621
Open Article
585
Why are brown bears protected against atherosclerosis even though their plasma cholesterol levels are twice that of humans?Eva Hurt-Camejo, Matteo Pedrelli
Clin Investig Arterioscler. 2022;34:322-5
585
Open access
Open Article
584
Prevalence rates of overweight and obesity and their associations with cardiometabolic and renal factors. SIMETAP-OB studyAntonio Ruiz-García, Ezequiel Arranz-Martínez, Luis Enrique Morales-Cobos, Juan Carlos García-Álvarez, Nerea Iturmendi-Martínez, Montserrat Rivera-Teijido
Clin Investig Arterioscler. 2022;34:291-302
584
Open Article
577
The future of diet: what will we be eating in The future?Francisco Pérez-Jiménez
Clin Investig Arterioscler. 2022;34 Supl 1:17-22
577
Open Article
544
Prevalence of prediabetes and association with cardiometabolic and renal factors. SIMETAP-PRED studyEzequiel Arranz-Martínez, Antonio Ruiz-García, Juan Carlos García Álvarez, Teresa Fernández Vicente, Nerea Iturmendi Martínez, Montserrat Rivera-Teijido
Clin Investig Arterioscler. 2022;34:193-204
544
Open Article
491
Statement of the Spanish Interdisciplinary Vascular Prevention Committee on the updated European Guidelines on Cardiovascular Disease PreventionCarlos Brotons, Miguel Camafort, María del Mar Castellanos, Albert Clarà, Olga Cortés, Angel Diaz Rodriguez, Roberto Elosua, Manuel Gorostidi, ... Pedro Armario
Clin Investig Arterioscler. 2022;34:219-28
491
Open Article